These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 17466227

  • 1. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
    Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM, PROactive Investigators.
    J Am Coll Cardiol; 2007 May 01; 49(17):1772-80. PubMed ID: 17466227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04).
    Wilcox R, Bousser MG, Betteridge DJ, Schernthaner G, Pirags V, Kupfer S, Dormandy J, PROactive Investigators.
    Stroke; 2007 Mar 01; 38(3):865-73. PubMed ID: 17290029
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Observational follow-up of the PROactive study: a 6-year update.
    Erdmann E, Song E, Spanheimer R, van Troostenburg de Bruyn AR, Perez A.
    Diabetes Obes Metab; 2014 Jan 01; 16(1):63-74. PubMed ID: 23859428
    [Abstract] [Full Text] [Related]

  • 10. [Evidences demonstrating the effects of anti-atherosclerotic actions of pioglitazone--special emphasis on PROactive Study and PERISCOPE Study].
    Kawamori R.
    Nihon Rinsho; 2010 Feb 01; 68(2):235-41. PubMed ID: 20158090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
    Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE, AleCardio Investigators.
    JAMA; 2014 Apr 16; 311(15):1515-25. PubMed ID: 24682069
    [Abstract] [Full Text] [Related]

  • 13. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K.
    Clin Ther; 2009 Nov 16; 31(11):2665-77. PubMed ID: 20110009
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone.
    Betteridge DJ.
    Fundam Clin Pharmacol; 2009 Dec 16; 23(6):675-9. PubMed ID: 19744248
    [Abstract] [Full Text] [Related]

  • 16. Organ protection in the secondary prevention of type 2 diabetes.
    Schernthaner G.
    Drugs Today (Barc); 2006 Dec 16; 42 Suppl C():17-23. PubMed ID: 17245477
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
    Spence JD, Viscoli CM, Inzucchi SE, Dearborn-Tomazos J, Ford GA, Gorman M, Furie KL, Lovejoy AM, Young LH, Kernan WN, IRIS Investigators.
    JAMA Neurol; 2019 May 01; 76(5):526-535. PubMed ID: 30734043
    [Abstract] [Full Text] [Related]

  • 19. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.
    Nissen SE, Wolski K, Topol EJ.
    JAMA; 2005 Nov 23; 294(20):2581-6. PubMed ID: 16239637
    [Abstract] [Full Text] [Related]

  • 20. A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study.
    Pfister R, Cairns R, Erdmann E, Schneider CA.
    Int J Cardiol; 2013 Jan 10; 162(2):112-6. PubMed ID: 21636144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.